Commentary: Precision Medicine Will Increase Drug Prices and That’s A Good Thing
PHE Senior Research Economist Jason Shafrin presents an interesting picture of the value and pricing of precision medicine, in a new commentary for MedCity News.
Commentary: Pharma Needs a New Prescription
Precision Health Economics founders Darius Lakdawalla and Dana Goldman contribute a new commentary for STAT News: “Election Verdict: Pharma Needs a New Prescription.”
Precision’s Galante and Hennessey Address Patient Engagement Tools in Medical Economics
Precision for Value’s Dominic Galante and Maureen Hennessey discuss the subject of patient engagement tools with Keith Loria from Medical Economics, and why more physicians aren’t using them.
PHE’s Jason Shafrin Discusses Value-Based Drug Pricing in HealthcareDIVE
Precision Health Economics’ senior research economist Jason Shafrin discusses value-based drug pricing and the benefits for payers in HealthcareDIVE.
Dan Renick Explains “The Wedge Strategy” in STAT News Article
Dan Renick, President of global market access specialists Precision for Value, explains “the wedge strategy”in a new article for STAT News.